Figure S5 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma od Sebastian Johannes Schober (14971891)

Hasła przedmiotowe:

Figure S2 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma od Sebastian Johannes Schober (14971891)

Hasła przedmiotowe:

Figure S4 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma od Sebastian Johannes Schober (14971891)

Hasła przedmiotowe:

Figure S3 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma od Sebastian Johannes Schober (14971891)

Hasła przedmiotowe:

Figure S1 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma od Sebastian Johannes Schober (14971891)

Hasła przedmiotowe:

Supplementary Table S2 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors od Clare F. Malone (14960925)

Hasła przedmiotowe:

Supplementary Table S3 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors od Clare F. Malone (14960925)

Hasła przedmiotowe:

Supplementary Table S1 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors od Clare F. Malone (14960925)

Hasła przedmiotowe:

Table S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution od Bahar Rastegar (16031079)

Hasła przedmiotowe:

Table S4 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution od Bahar Rastegar (16031079)

Hasła przedmiotowe:

Table S3 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution od Bahar Rastegar (16031079)

Hasła przedmiotowe:

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma od Gia-Buu Tran (16437051)

Hasła przedmiotowe:

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma od Gia-Buu Tran (16437051)

Hasła przedmiotowe:

Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma od Gia-Buu Tran (16437051)

Hasła przedmiotowe:

Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma od Gia-Buu Tran (16437051)

Hasła przedmiotowe:

Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma od Gia-Buu Tran (16437051)

Hasła przedmiotowe:

Supplementary Data- Tables TS1-6 from Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clin... od Rose B. McGee (15056564)

Hasła przedmiotowe:

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group od David Milewski (15050643)

Hasła przedmiotowe:

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group od David Milewski (15050643)

Hasła przedmiotowe:

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group od David Milewski (15050643)

Hasła przedmiotowe: